BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2105158)

  • 1. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.
    Offermann MK; Faller DV
    Cancer Res; 1990 Feb; 50(3):601-5. PubMed ID: 2105158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine induction of major histocompatibility complex class I antigen expression results from induction of beta interferon in oncogene-transformed BALB/c-3T3 cells.
    Offermann MK; Faller DV
    Mol Cell Biol; 1989 May; 9(5):1969-77. PubMed ID: 2664464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced stimulation of helper T cells by Ki-ras transformed cells.
    Maudsley DJ; Bateman WJ; Morris AG
    Immunology; 1991 Feb; 72(2):277-81. PubMed ID: 1826672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex antigens in v-Ki-ras transformed cells: the different antigens are expressed and induced by interferons independently of one another and of the anti-viral state.
    Morris AG
    Immunology; 1990 Oct; 71(2):224-9. PubMed ID: 1699881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J; Moyana T
    Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. II. Effects on class II antigen expression.
    Maudsley DJ; Morris AG
    Immunology; 1989 May; 67(1):26-31. PubMed ID: 2544514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of MHC expression in vivo. II. IFN-alpha/beta inducers and recombinant IFN-alpha modulate MHC antigen expression in mouse tissues.
    Halloran PF; Urmson J; Van der Meide PH; Autenried P
    J Immunol; 1989 Jun; 142(12):4241-7. PubMed ID: 2498428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
    Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IFN-gamma-induced host cell MHC antigen expression by Kirsten MSV and MLV. I. Effects on class I antigen expression.
    Maudsley DJ; Morris AG
    Immunology; 1989 May; 67(1):21-5. PubMed ID: 2544513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of major histocompatibility complex class I antigens in normal and transformed rat thyroid epithelial cell lines.
    Fontana S; Del Vecchio L; Racioppi L; Carbone E; Pinto A; Colletta G; Zappacosta S
    Cancer Res; 1987 Aug; 47(15):4178-83. PubMed ID: 3607759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered H1 histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes.
    Blackmore PF; Oakes SG; Somers KD
    Oncogene; 1992 Oct; 7(10):2053-7. PubMed ID: 1408146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of major histocompatibility complex antigens in squamous cell carcinomas of the head and neck: effects of interferon gene transfer.
    Arosarena OA; Baranwal S; Strome S; Wolf GT; Krauss JC; Bradford CR; Carey TE
    Otolaryngol Head Neck Surg; 1999 May; 120(5):665-71. PubMed ID: 10229590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
    Stemme S; Fager G; Hansson GK
    Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.